Sign in

CIK 0002058707 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Attovia Therapeutics, Inc.

Sign in to watch
Ticker
ATTO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
921510574
Phone
5103995001
Business address
1091 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-06 WALSH COLIN Director Purchase +500,000 $17.00 $8.5M 3,020,632
2026-08-06 GOLDMAN SACHS GROUP INC Former 10% Owner Purchase +500,000 $17.00 $8.5M 3,020,632
2026-08-06 WALSH COLIN Director Purchase +500,000 $17.00 $8.5M 3,020,632
2026-08-06 GOLDMAN SACHS GROUP INC Former 10% Owner Purchase +500,000 $17.00 $8.5M 3,020,632
2026-08-06 venBio Global Strategic Fund IV, L.P. 10% owner Purchase +382,352 $17.00 $6.5M 4,181,367
2026-08-06 Sanofi 10% owner Purchase +300,000 $17.00 $5.1M 1,082,855
2026-08-06 Redmile Group, LLC 10% owner Purchase +200,000 $17.00 $3.4M 982,854
2026-08-06 Redmile Group, LLC 10% owner Purchase +400,000 $17.00 $6.8M 1,182,854
2026-08-06 Frazier Life Sciences XI, L.P. 10% owner Purchase +588,235 $17.00 $10.0M 6,154,213
2026-08-05 WALSH COLIN Director Purchase +85,000 $21.00 $1.8M 85,000
2026-08-05 GOLDMAN SACHS GROUP INC Former 10% Owner Purchase +85,000 $21.00 $1.8M 85,000
2026-08-05 WALSH COLIN Director Purchase +85,000 $21.00 $1.8M 85,000
2026-08-05 GOLDMAN SACHS GROUP INC Former 10% Owner Purchase +85,000 $21.00 $1.8M 85,000

Page 1 of 1 · 13 trades